Skip to Content
Get expert answers to vaginal health questions. Go >

Menotropins Pregnancy and Breastfeeding Warnings

Menotropins is also known as: Humegon, Menopur, Pergonal, Repronex

Menotropins Pregnancy Warnings

Use during pregnancy is contraindicated AU TGA pregnancy category: C US FDA pregnancy category: X

There are no adequate animal studies. There are no controlled data in human pregnancy. Based on its pharmacology and reproductive studies conducted with similar products, an increase in embryonic resorptions and post-implantation loss may be expected at clinically relevant doses. AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details. US FDA pregnancy category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.

See references

Menotropins Breastfeeding Warnings

AU, UK: Contraindicated US: A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Data not available

See references

References for pregnancy information

  1. "Product Information. Repronex (menotropins)." Ferring Pharmaceuticals Inc, Tarrytown, NY.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. "Product Information. Menopur (menotropins)." Ferring Pharmaceuticals Inc, Tarrytown, NY.
  4. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. "Product Information. Menopur (menotropins)." Ferring Pharmaceuticals Inc, Tarrytown, NY.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  4. "Product Information. Repronex (menotropins)." Ferring Pharmaceuticals Inc, Tarrytown, NY.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide